Talk:NDV-HXP-S
Appearance
This is the talk page for discussing improvements to the NDV-HXP-S article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Suggest changing the title of the article to 'NDV-HXP-S vaccine for COVID-19' or something similar once the redirects due to my attempts have been corrected by an admin. JuanTamad (talk) 05:09, 10 April 2021 (UTC)
Duplicate
[edit]As pointed out by the merge suggestion, there were two articles on the subject created a few hours apart. Of these, this one is better developed and sourced by far. Accordingly I've redirected NDV-HXP-S COVID-19 vaccine here. Whether the two names should now be switched is another matter. --Elmidae (talk · contribs)
- Actually, I'll just go ahead and do that. --Elmidae (talk · contribs) 21:39, 10 April 2021 (UTC)
Merge proposal
[edit]I just proposed that Vietnamese vaccine be merged into the article, as of that, It is the same dub of a vaccine trial in Vietnam. 1 2 3 Abrilando232 (talk) 01:28, 24 June 2021 (UTC)
- I think they should be merged indeed. It is just another comercial name to "NDV-HXP-S"--MuriloHDD (talk) 23:42, 25 June 2021 (UTC)
- Makes sense to me. --Fernando Trebien (talk) 13:11, 27 June 2021 (UTC)